SEC Form 3 · accession 0001457612-18-000103
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Narinderjeet Singh
Officer — SENIOR VP, PS&M
Period of report
Oct 11, 2018
Accepted (ET)
Oct 12, 2018 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 20,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.21 | holding | — | — | — | — | Mar 12, 2028 | Common Stock | 200,000 | — | D |
Explanation of responses
- F1The Stock Option will vest as to 1/4th of the Shares subject to the option on the first anniversary of the vesting start date (3/12/18) and thereafter as to 1/48th of such Shares (rounded down to the nearest whole share except for the fourth anniversary of the vesting start date, with respect to which all remaining shares will vest) on each of the next 36 consecutive monthly anniversaries following the first anniversary of the vesting start date.
Remarks
Exhibit List - Exhibit 24 Power of Attorney